Screening of cell cycle fusion proteins to identify kinase signaling networks

被引:1
作者
Trojanowsky, Michelle [1 ]
Vidovic, Dusica [2 ]
Simanski, Scott [3 ]
Penas, Clara [1 ]
Schurer, Stephan [2 ]
Ayad, Nagi G. [1 ]
机构
[1] Univ Miami, Dept Psychiat & Behav Sci, Ctr Therapeut Innovat, Miami, FL 33177 USA
[2] Univ Miami, Dept Pharmacol, Miami, FL USA
[3] Scripps Florida, Dept Canc Biol, Jupiter, FL USA
关键词
cell cycle; degradation; kinases; signaling networks; ubiquitin; GLYCOGEN-SYNTHASE KINASE-3-BETA; PHORBOL; 12-MYRISTATE; 13-ACETATE; CDK INHIBITOR P27; BREAST-CANCER; DEPENDENT PHOSPHORYLATION; MUTATIONAL ANALYSIS; MOLECULAR ANALYSIS; P27(KIP1) GENE; PIM-1; KINASE; LUNG-CANCER;
D O I
10.1080/15384101.2015.1006987
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Kinase signaling networks are well-established mediators of cell cycle transitions. However, how kinases interact with the ubiquitin proteasome system (UPS) to elicit protein turnover is not fully understood. We sought a means of identifying kinase-substrate interactions to better understand signaling pathways controlling protein degradation. Our prior studies used a luciferase fusion protein to uncover kinase networks controlling protein turnover. In this study, we utilized a similar approach to identify pathways controlling the cell cycle protein p27(Kip1). We generated a p27(Kip1)-luciferase fusion and expressed it in cells incubated with compounds from a library of pharmacologically active compounds. We then compared the relative effects of the compounds on p27(Kip1)-luciferase fusion stabilization. This was combined with in silico kinome profiling to identify potential kinases inhibited by each compound. This approach effectively uncovered known kinases regulating p27(Kip1) turnover. Collectively, our studies suggest that this parallel screening approach is robust and can be applied to fully understand kinase-ubiquitin pathway interactions.
引用
收藏
页码:1274 / 1281
页数:8
相关论文
共 65 条
[51]   MAMMALIAN G(1)-CYCLINS [J].
SHERR, CJ .
CELL, 1993, 73 (06) :1059-1065
[52]  
Spirin KS, 1996, CANCER RES, V56, P2400
[53]  
Stegmaier K, 1996, CANCER RES, V56, P1413
[54]   p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells [J].
Sutterlüty, H ;
Chatelain, E ;
Marti, A ;
Wirbelauer, C ;
Senften, M ;
Müller, U ;
Krek, W .
NATURE CELL BIOLOGY, 1999, 1 (04) :207-214
[55]   Activation of protein kinase C by phorbol 12-myristate 13-acetate suppresses the growth of lung cancer cells through KLF6 induction [J].
Tahara, Eiji ;
Kadara, Humam ;
Lacroix, Ludovic ;
Lotan, Dafna ;
Lotan, Reuben .
CANCER BIOLOGY & THERAPY, 2009, 8 (09) :801-807
[56]  
Tan P, 1997, CANCER RES, V57, P1259
[57]   P27, A NOVEL INHIBITOR OF G1 CYCLIN-CDK PROTEIN-KINASE ACTIVITY, IS RELATED TO P21 [J].
TOYOSHIMA, H ;
HUNTER, T .
CELL, 1994, 78 (01) :67-74
[58]   Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO) [J].
Vempati, Uma D. ;
Przydzial, Magdalena J. ;
Chung, Caty ;
Abeyruwan, Saminda ;
Mir, Ahsan ;
Sakurai, Kunie ;
Visser, Ubbo ;
Lemmon, Vance P. ;
Schuerer, Stephan C. .
PLOS ONE, 2012, 7 (11)
[59]   Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain [J].
Verma, R ;
Peters, NR ;
D'Onofrio, M ;
Tochtrop, GP ;
Sakamoto, KM ;
Varadan, R ;
Zhang, MS ;
Coffino, P ;
Fushman, D ;
Deshaies, RJ ;
King, RW .
SCIENCE, 2004, 306 (5693) :117-120
[60]   Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1) [J].
Vlach, J ;
Hennecke, S ;
Amati, B .
EMBO JOURNAL, 1997, 16 (17) :5334-5344